Position in DHR
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$1,507,839
+$18,531 QoQ
Shares Held
7,916
+0.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#962
of 2,092 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Fragasso Financial Advisors Inc holds $5,684,240 across 5 Diagnostics & Research names. DHR ranks #3 (26.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LH |
Labcorp Holdings Inc.
|
7,047 | $1,973,160 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
3,197 | $1,602,847 | |
| 3 | DHR |
Danaher Corp /De/
This page
|
7,916 | $1,507,839 | |
| 4 | CRL |
Charles River Laboratories International, Inc.
|
1,524 | $345,627 | |
| 5 | A |
Agilent Technologies, Inc.
|
1,918 | $254,767 |
All Filings in DHR
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,507,839 | 7,916 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $1,489,308 | 7,855 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $1,841,432 | 8,044 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $1,672,124 | 8,434 | Shares | Sole | 2025-10-06 | |
| 2025-06-30 | $215,516 | 1,091 | Shares | Sole | 2025-07-09 | |
| 2024-12-31 | $252,275 | 1,099 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $318,610 | 1,146 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $261,343 | 1,046 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $254,714 | 1,020 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $319,017 | 1,379 | Shares | Sole | 2024-01-08 | |
| No filing history on record for this holder in this stock. | ||||||